Corrigendum to "Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis" [Clin. Immunol. 288 (2026) 110766].
Okuda DT, Anderson BJ, Taylor SM, Jones-McCreary MC, Burgess KW, Wright CM, Santoyo JR, Sguigna PV, Stüve O, Tran DH, et al.
